• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力中的促炎细胞因子:系统评价与荟萃分析

Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis.

作者信息

Shushtari Ali, Ashayeri Hamidreza, Salmannezhad Amirhossein, Seyedmirzaei Homa, Rezaei Nima

机构信息

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Neurol Sci. 2025 May 10. doi: 10.1007/s10072-025-08218-3.

DOI:10.1007/s10072-025-08218-3
PMID:40347402
Abstract

BACKGROUND

Myasthenia gravis (MG) is an autoimmune neuromuscular disorder impacting muscle endplate components. Pro-inflammatory cytokines, particularly, might play pivotal roles in MG pathogenesis, influencing regulatory T cells and contributing to chronic inflammation. We did this systematic review and meta-analysis to address the conflicting results about pro-inflammatory cytokine profiles in MG.

METHODS

A thorough search was conducted in PubMed, Scopus, and Embase to find studies measuring interleukin (IL)-1 family (IL-1β, IL-18, IL-33, IL-36, IL-37), IL-6, and tumor necrosis factor-alpha (TNF-α) levels in MG patients' serum and controls. Selection criteria encompassed various MG types, including ocular and generalized, with and without thymoma, and acetylcholine receptor (AChR) antibody-positive and negative.

RESULTS

Of the 1843 identified studies, 16 met the inclusion criteria. The meta-analysis revealed a significant increase in serum TNF-α, IL-1β, and IL-33 level in MG patients compared to controls. The included studies also implied elevated levels of IL-18 in people with MG compared to controls and elevated levels of IL-18 and IL-33 in generalized MG compared to ocular MG.

CONCLUSION

Our study highlights the altered profiles of pro-inflammatory cytokines in MG.

摘要

背景

重症肌无力(MG)是一种自身免疫性神经肌肉疾病,会影响肌肉终板成分。特别是促炎细胞因子可能在MG发病机制中起关键作用,影响调节性T细胞并导致慢性炎症。我们进行了这项系统评价和荟萃分析,以解决关于MG中促炎细胞因子谱的相互矛盾的结果。

方法

在PubMed、Scopus和Embase中进行了全面检索,以查找测量MG患者血清和对照组中白细胞介素(IL)-1家族(IL-1β、IL-18、IL-33、IL-36、IL-37)、IL-6和肿瘤坏死因子-α(TNF-α)水平的研究。选择标准包括各种MG类型,包括眼肌型和全身型,有或无胸腺瘤,以及乙酰胆碱受体(AChR)抗体阳性和阴性。

结果

在1843项已识别的研究中,16项符合纳入标准。荟萃分析显示,与对照组相比,MG患者血清TNF-α、IL-1β和IL-33水平显著升高。纳入的研究还表明,与对照组相比,MG患者的IL-18水平升高,与眼肌型MG相比,全身型MG的IL-18和IL-33水平升高。

结论

我们的研究突出了MG中促炎细胞因子谱的改变。

相似文献

1
Pro-inflammatory cytokines in myasthenia gravis: a systematic review and meta-analysis.重症肌无力中的促炎细胞因子:系统评价与荟萃分析
Neurol Sci. 2025 May 10. doi: 10.1007/s10072-025-08218-3.
2
Serum cytokine profiles in patients with myasthenia gravis.重症肌无力患者的血清细胞因子谱
Front Neurol. 2025 Jul 3;16:1611673. doi: 10.3389/fneur.2025.1611673. eCollection 2025.
3
Immune Modulatory Effects of PD-1/PD-L1 in Myasthenia Gravis: Insights From Peripheral Blood Mononuclear Cell Analysis.PD-1/PD-L1在重症肌无力中的免疫调节作用:来自外周血单个核细胞分析的见解
FASEB J. 2025 Aug 15;39(15):e70827. doi: 10.1096/fj.202500887R.
4
Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4CD8 thymocytes.重症肌无力患者的 B 型胸腺瘤在 CD4CD8 胸腺细胞上表达独特的 αβ TCR 和 IL-7 受体 α 模式。
Autoimmunity. 2024 Apr 27;57(1):2347379. doi: 10.1080/08916934.2024.2347379. Epub 2024 May 9.
5
Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.精神分裂症急性和慢性期外周细胞因子及相关炎症蛋白浓度的变化模式:一项系统评价和网状Meta分析
Lancet Psychiatry. 2023 Apr;10(4):260-271. doi: 10.1016/S2215-0366(23)00025-1. Epub 2023 Feb 27.
6
Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling.蛋白质组学分析揭示重症肌无力患者T细胞中的炎症失衡与激活缺陷
Front Immunol. 2025 Aug 4;16:1648020. doi: 10.3389/fimmu.2025.1648020. eCollection 2025.
7
Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization study.循环炎症细胞因子与重症肌无力风险:一项双向孟德尔随机化研究
BMC Neurol. 2025 Jul 1;25(1):271. doi: 10.1186/s12883-025-04271-9.
8
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literature.家族性重症肌无力:以色列队列的特征及文献系统综述
J Neurol. 2025 Jul 10;272(8):498. doi: 10.1007/s00415-025-13236-4.
9
Association of blocking acetylcholine receptor antibodies with clinical subtypes and disease severity in myasthenia gravis.重症肌无力中抗乙酰胆碱受体抗体与临床亚型及疾病严重程度的关联
Clin Chim Acta. 2025 Sep 1;577:120449. doi: 10.1016/j.cca.2025.120449. Epub 2025 Jun 25.
10
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.在重症肌无力(MG-001)中自体 RNA 嵌合抗原受体 T 细胞治疗的安全性和临床活性:前瞻性、多中心、开放标签、非随机 1b/2a 期研究。
Lancet Neurol. 2023 Jul;22(7):578-590. doi: 10.1016/S1474-4422(23)00194-1.

本文引用的文献

1
Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies.抗肌肉特异性激酶抗体阳性的重症肌无力患者的血清细胞因子谱。
J Neuroimmunol. 2023 Nov 15;384:578205. doi: 10.1016/j.jneuroim.2023.578205. Epub 2023 Sep 20.
2
The relationship between serum iron levels and AChR-Ab and IL-6 in patients with myasthenia gravis.重症肌无力患者血清铁水平与 AChR-Ab 和 IL-6 的关系。
Eur Rev Med Pharmacol Sci. 2023 Jan;27(1):98-102. doi: 10.26355/eurrev_202301_30857.
3
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment.
白细胞介素-18 细胞因子在免疫、炎症和自身免疫中的作用:诱导、调节和治疗中的生物学作用。
Front Immunol. 2022 Aug 11;13:919973. doi: 10.3389/fimmu.2022.919973. eCollection 2022.
4
FoxP3 Tr1 Cell in Generalized Myasthenia Gravis and Its Relationship With the Anti-AChR Antibody and Immunomodulatory Cytokines.重症肌无力中FoxP3调节性1型细胞及其与抗乙酰胆碱受体抗体和免疫调节细胞因子的关系。
Front Neurol. 2021 Dec 17;12:755356. doi: 10.3389/fneur.2021.755356. eCollection 2021.
5
The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics.肿瘤坏死因子α(TNF-α)在自身免疫性疾病中的作用及目前 TNF-α 抑制剂在治疗中的应用。
Int J Mol Sci. 2021 Mar 8;22(5):2719. doi: 10.3390/ijms22052719.
6
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
Int J Surg. 2021 Apr;88:105906. doi: 10.1016/j.ijsu.2021.105906. Epub 2021 Mar 29.
7
In-depth peripheral CD4 T profile correlates with myasthenic crisis.深入的外周 CD4 T 谱与肌无力危象相关。
Ann Clin Transl Neurol. 2021 Apr;8(4):749-762. doi: 10.1002/acn3.51312. Epub 2021 Feb 22.
8
The IL-1 family cytokines and receptors in autoimmune diseases.白介素-1 家族细胞因子及其受体与自身免疫性疾病。
Autoimmun Rev. 2020 Sep;19(9):102617. doi: 10.1016/j.autrev.2020.102617. Epub 2020 Jul 12.
9
Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.比较眼肌型和全身型重症肌无力患者外周血 B 细胞亚群比值和 B 细胞相关细胞因子水平。
Int Immunopharmacol. 2020 Mar;80:106130. doi: 10.1016/j.intimp.2019.106130. Epub 2020 Jan 21.
10
Myasthenia gravis and specific immunotherapy: monoclonal antibodies.重症肌无力与特异性免疫治疗:单克隆抗体。
Ann N Y Acad Sci. 2019 Sep;1452(1):18-33. doi: 10.1111/nyas.14195. Epub 2019 Aug 8.